Back to Search Start Over

Amburoside A, a glucoside from Amburana cearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity

Authors :
H.V. Nobre Júnior
Geanne M. A. Cunha
Manoel Odorico de Moraes
Cláudia Pessoa
R.A. Oliveira
Edilberto R. Silveira
K. M. Canuto
G.S.B. Viana
Luzia Kalyne Almeida Moreira Leal
Source :
Neuroscience Letters. 388:86-90
Publication Year :
2005
Publisher :
Elsevier BV, 2005.

Abstract

This study evaluates the potential neuroprotective properties of amburoside A, a glucoside isolated from Amburana cearensis, on rat mesencephalic cell cultures exposure to the neurotoxin 6-hydroxydopamine (6-OHDA). The parameters determined were cell viability by the 3[4,5-dimethylthiazole-2-il]-2,5-diphenyltetrazolium bromide (MTT) method, nitric oxide (NO) and free radical formation by the measurement of nitrite concentration and thiobarbituric acid reacting substance (TBARS) formation as an indication of cellular lipid peroxidation. The results showed that AMB was less effective as a curative agent in the MTT assay, since its addition after 6-OHDA did not reverse the neurotoxin's effect, except at the highest concentration (AMB, 100 microg/ml). Similarly, the higher nitrite levels observed after exposure of the cells to 6-OHDA were only partially reversed by AMB, at this highest concentration. However, when AMB (0.5, 1, 10 and 100 microg/ml) was added before the toxin, it appeared to protect neuronal cells against 6-OHDA toxicity in a concentration-dependent manner, as shown by MTT assay. AMB also prevented free radical formation indicated by the increased nitrite concentration induced by 6-OHDA. Cells exposed to 6-OHDA showed a 3.4 times increase in TBARS concentration as compared to controls, and this effect was inhibited from 24% up to 64% by AMB (0.1-100 microg/ml), indicative of a neuroprotective effect. In conclusion, we show that AMB, acting as an antioxidant compound, presents a significant neuroprotective effect, suggesting that this compound could provide benefits as a therapeutic agent in neurodegenerative disease such as Parkinson's.

Details

ISSN :
03043940
Volume :
388
Database :
OpenAIRE
Journal :
Neuroscience Letters
Accession number :
edsair.doi.dedup.....22333b2c8f2051bfc7a05f20aeeafaf7
Full Text :
https://doi.org/10.1016/j.neulet.2005.06.034